TDO2 and metabolic dysfunction-associated steatohepatitis: Our results indicate that disease-related factors promote the upregulation of tryptophan 2,3-dioxygenase (Tdo2) in the liver, which could help maintain local Trp degradation and prevent the aggravation of NASH.